One Patient Agenda for 2027: Is It Time to Bring Risk and Quality Together?
This complimentary webinar is brought to you by
Risk adjustment and quality teams often work from different patient lists, use different processes, and make separate requests of the same providers. As organizations prepare for 2027, is that separation still serving them?
Mark Reardon, MD, MBA, and Colin Reardon, MA, MAS will explore how, following recent regulatory changes, risk adjustment and quality teams should share clinical information and coordinate what reaches the provider before a visit. Using chronic kidney disease as a practical example, they will examine what happens when test results, diagnosis codes, and quality records disagree, and how those differences can help teams prioritize patients for assessment and follow-up. The discussion will connect clinical evidence to everyday decisions about provider workload, documentation, and care.
Topics at a Glance
- What CMS policy changes and audit activity mean for coordination between risk adjustment and quality.
- How competing patient lists create extra work for providers, and what a shared patient agenda could look like.
- Where differences between clinical findings, diagnosis codes, and quality records reveal opportunities for follow-up.
- Chronic kidney disease as a worked example of coding assessment and clinical review.
- Turning findings into action through provider education, test completion, and follow-up visits.
Who Should Attend
- Risk adjustment directors and managers; HCC coding and clinical documentation leaders.
- Quality improvement, HEDIS, and Stars leaders.
- Chief medical officers and medical directors.
- Population health, care management, and clinical operations leaders.
- Value-based care and analytics executives at health plans, ACOs, and risk-bearing provider groups.
